HNRNPR: A Potential Drug Target and Biomarker (G10236)

Target Name: HNRNPR

NCBI ID: G10236

HNRNPR

HNRNPR: A Potential Drug Target and Biomarker

HNRNPR (Hetero nuclear rRNA gene 1, also known as HNRNPR variant 1) is a gene that has been identified as a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and respiratory diseases.

The HNRNPR gene is located on chromosome 6p21.2 and encodes a non-coding RNA molecule that plays a role in the regulation of gene expression. Studies have shown that the HNRNPR gene is expressed in a wide range of tissues and cells, including brain, heart, liver, and muscle.

One of the key features of the HNRNPR gene is its ability to interact with other genes. Studies have shown that the HNRNPR gene can form a complex with the protein RNA-protein interactions (RISC) complex, which is involved in the regulation of gene expression. This interaction between the HNRNPR gene and RISC suggests that the HNRNPR gene may be a good candidate for drug targeting.

Another feature of the HNRNPR gene is its expression pattern. Studies have shown that the HNRNPR gene is highly expressed in a variety of tissues and cells, including cancer cells. This suggests that the HNRNPR gene may be a useful biomarker for cancer diagnosis and treatment.

In addition to its potential drug target and biomarker properties, the HNRNPR gene is also of interest to researchers because of its location on chromosome 6p21.2. This location suggests that it may be involved in the regulation of gene expression in the developing nervous system. Studies have shown that the HNRNPR gene is expressed in the brain and that it is involved in the regulation of neuron migration and synaptic plasticity. This suggests that the HNRNPR gene may be a promising target for drugs that are effective in treating neurodegenerative diseases.

Overall, the HNRNPR gene is a promising candidate for drug targeting and biomarker research. Further studies are needed to fully understand its function and potential as a drug target and biomarker.

Protein Name: Heterogeneous Nuclear Ribonucleoprotein R

Functions: Component of ribonucleosomes, which are complexes of at least 20 other different heterogeneous nuclear ribonucleoproteins (hnRNP). hnRNP play an important role in processing of precursor mRNA in the nucleus

The "HNRNPR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HNRNPR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets